Resilience-Building Intervention for Advance Care Planning
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how Chinese Americans in Chicago discuss advance care planning (ACP) with family and religious leaders, particularly when facing cancer, high blood pressure (hypertension), or heart disease. Participants will either complete a survey or participate in an interview to share their experiences. The study seeks to gather insight into people's readiness for these important conversations and the support they might need. Chinese Americans in Chicago, especially those experienced in end-of-life discussions or managing chronic illnesses, may be well-suited for this trial. As an unphased study, this trial offers participants the chance to contribute to valuable cultural insights and enhance support systems for advance care planning.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this resilience-building intervention is safe for advance care planning?
Research has shown that resilience-building activities, especially those that respect cultural differences, are generally easy for people to handle. These activities aim to provide emotional and psychological support without introducing new medications or physical treatments.
Studies on similar activities for Chinese Americans have indicated that these methods help people discuss end-of-life care without causing harm. Reports have not documented any serious side effects or negative outcomes from these activities. The main goal is to improve communication and understanding, which is naturally low-risk.
In summary, current evidence considers the resilience-building activities in this trial safe. Participants can expect to engage in supportive activities and conversations designed to assist them and their families with advance care planning.12345Why are researchers excited about this trial?
Researchers are excited about this resilience-building intervention for advance care planning because it is culturally tailored specifically for Chinese Americans, a group that often faces unique challenges in end-of-life care discussions. Unlike standard care options that may not address cultural nuances, this intervention aims to enhance communication and decision-making by considering cultural beliefs and practices. By involving not just individuals but also religious leaders and family members, the intervention seeks to provide a holistic approach that could lead to more meaningful and effective advance care planning.
What evidence suggests that this resilience-building intervention is effective for advance care planning?
Research has shown that specially designed programs can increase Chinese Americans' participation in advance care planning (ACP). Studies reveal that fewer than 15% of Chinese Americans complete these plans, compared to 37% of the general U.S. population. This trial will test a culturally tailored resilience-building intervention to close that gap by respecting cultural differences, especially for those with cancer or heart disease. Early results suggest these programs can facilitate more meaningful discussions about ACP for Chinese American families. By focusing on cultural understanding, the program aims to improve communication about end-of-life care.12345
Are You a Good Fit for This Trial?
This trial is for Chinese Americans over 18 with cancer or heart failure who have a family caregiver willing to join the study. Participants must be able to respond in English or Mandarin and have their diagnosis recorded in medical records.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention Development
Development of a culturally tailored resilience-building intervention for Chinese Americans with cancer or heart disease
Usability Testing
Usability test of the resilience-building intervention prototype with 18 pairs of Chinese Americans and their family caregivers
Follow-up
Participants are monitored for acceptability of the intervention immediately after usability testing
What Are the Treatments Tested in This Trial?
Interventions
- Culturally tailored resilience-building intervention
Culturally tailored resilience-building intervention is already approved in United States for the following indications:
- Advance Care Planning Discussions for Chinese Americans with Cancer or Heart Disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
University of Chicago
Collaborator
Rush University Medical Center
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator